Evidence map›Paper›PMID 16630951›Full record

Trial reportThe Journal of allergy and clinical immunology2006

Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.

Akihiko Saitoh, Kumud K Singh, Sharsti Sandall, Christine A Powell, Terrence Fenton, Courtney V Fletcher, Karen Hsia, Stephen A Spector

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Recent Thymus Emigrant CD4+ T Cells Predict HIV Disease Progression in Patients With Perinatally Acquired HIV.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Akihiko SaitohDepartment of Pediatrics, Division of Infectious Diseases, University of California, San Diego, La Jolla 92093-0672, USA.
Kumud K Singh
Sharsti Sandall
Christine A Powell
Terrence Fenton
Courtney V Fletcher
Karen Hsia
Stephen A Spector
Office of Infectious Diseases · USHarvard University · USUniversity of Colorado Health · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
ZOVIRAX CREAM TO TREAT HERPES LABIALIS IN ADOLESCENTSM01RR000827 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, R JEFFREY · 1985 to 2010
$74.3M
PEDIATRIC AIDS CLINICAL TRIALS GROUP--COORDINATE/OPERATEU01AI041089 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI SPECTOR, STEPHEN A · 1997 to 2005
$71.9M
Statistical/Data Management Center-Pediatric AIDS CTGU01AI041110 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI FENTON, TERRENCE · 1997 to 2006
$38.6M
PHILADELPHIA PEDIATRIC AIDS CLINICAL TRIAL UNITU01AI032921 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI DOUGLAS, STEVEN DANIEL · 1992 to 2006
$6.7M
PEDIATRIC AIDS CLINICAL TRIALS GROUPU01AI027563 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SPECTOR, STEPHEN A · 1988 to 2006
$6.4M
PEDIATRIC AIDS--FACTORS IN TRANSMISSION AND PATHOLOGYR01AI039004 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SPECTOR, STEPHEN A · 1995 to 2005
$1.5M
CONCENTRATION-CONTROLLED ANTIRETROVIRAL THERAPYR01AI033835 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI FLETCHER, COURTNEY V. · 1993 to 2005
$1.5M
NCRR NIH HHS M01 RR000827NIAID NIH HHS AI-27563NIAID NIH HHS AI-32921NIAID NIH HHS AI-33835NIAID NIH HHS AI-36214NIAID NIH HHS AI-39004NIAID NIH HHS AI-41110NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI033835NIAID NIH HHS R01 AI039004NIAID NIH HHS U01 AI027563NIAID NIH HHS U01 AI032921NIAID NIH HHS U01 AI041089NIAID NIH HHS U01 AI041110
6 · The paper itself

Abstract

backgroundIn a cohort of children receiving highly active antiretroviral therapy (HAART) with sustained plasma HIV-1 RNA < 50 copies/mL, children who reached undetectable RNA after week 8 (slow responders, median: week 20) had higher HIV-1 intracellular DNA (HIV-1 DNA) and equal or greater CD4+ T-lymphocyte counts compared with children who reached undetectable plasma HIV-1 RNA by week 8 (rapid responders) throughout HAART.

objectiveTo determine whether levels of T-cell receptor excision circles (TRECs) could explain the apparent inconsistency between the quantity of HIV-1 DNA and CD4+ T-lymphocyte counts in HIV-1-infected children receiving HAART with sustained virologic suppression.

methodsT-cell receptor excision circles and HIV-1 DNA and plasma HIV-1 RNA were quantified longitudinally by PCR in 31 children (median age, 5.6 years) with sustained undetectable plasma HIV-1 RNA for >104 weeks of HAART.

resultsThere was a positive correlation between TREC and HIV-1 DNA during HAART, notably at weeks 48 and 80 (P < .004). During the early stage of HAART, TREC levels positively correlated with CD4+ T-lymphocyte percentages (P < .02) and naive CD4+ T-lymphocyte counts (P < .001) and percentages (P = .05). Median TREC levels were consistently equal or higher in slow responders compared with rapid responders (P < .001) despite slow responders having consistently greater quantities of HIV-1 DNA.

conclusionTo maintain adequate levels of CD4+ T-lymphocytes, children with high HIV-1 DNA maintain high levels of TREC while receiving HAART. Thus, a thymic control mechanism is required to maintain new CD4+ T lymphocytes in the presence of persistent virus. CLINICAL IMPLICATIONS: The TREC level is a useful marker of thymic function in HIV-infected children.

Indexed as

Antiretroviral Therapy, Highly ActiveCD4 Lymphocyte CountAdolescentBase SequenceChildChild, PreschoolCohort StudiesDNADNA, ViralGene Rearrangement, T-LymphocyteHIV-1HIV InfectionsHumansRNA, ViralThymus GlandDNADNA, ViralRNA, Viral

Identifiers

PMID16630951
PMCPMC2756961
OpenAlexW1970863063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.